This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jan-Feb;19(1):56.

doi: 10.4103/1319-3767.105930.

Rifaximin as treatment for hepatic encephalopathy: some considerations

Lorenzo Ridola, Angelo Zullo, Cesare Hassan

PMID: 23319040
PMCID: PMC3603492
DOI: 10.4103/1319-3767.105930

Comment

Rifaximin as treatment for hepatic encephalopathy: some considerations

Lorenzo Ridola et al. Saudi J Gastroenterol. 2013 Jan-Feb.

. 2013 Jan-Feb;19(1):56.

doi: 10.4103/1319-3767.105930.

Authors

Lorenzo Ridola, Angelo Zullo, Cesare Hassan

PMID: 23319040
PMCID: PMC3603492
DOI: 10.4103/1319-3767.105930

No abstract available

PubMed Disclaimer

Comment on

Hepatic encephalopathy.
Bleibel W, Al-Osaimi AM. Bleibel W, et al. Saudi J Gastroenterol. 2012 Sep-Oct;18(5):301-9. doi: 10.4103/1319-3767.101123. Saudi J Gastroenterol. 2012. PMID: 23006457 Free PMC article. Review.

Similar articles

Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis.
Bajaj JS. Bajaj JS. Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:11-26. doi: 10.1111/apt.13435. Aliment Pharmacol Ther. 2016. PMID: 26618922 Review.
Hepatic encephalopathy.
Bleibel W, Al-Osaimi AM. Bleibel W, et al. Saudi J Gastroenterol. 2012 Sep-Oct;18(5):301-9. doi: 10.4103/1319-3767.101123. Saudi J Gastroenterol. 2012. PMID: 23006457 Free PMC article. Review.
ABC of diseases of liver, pancreas, and biliary system: portal hypertension-2. Ascites, encephalopathy, and other conditions.
Krige JE, Beckingham IJ. Krige JE, et al. BMJ. 2001 Feb 17;322(7283):416-8. doi: 10.1136/bmj.322.7283.416. BMJ. 2001. PMID: 11179165 Free PMC article. Review. No abstract available.
Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
Chang CC, Lee WS, Chuang CL, Hsin IF, Hsu SJ, Chang T, Huang HC, Lee FY, Lee SD. Chang CC, et al. Eur J Pharmacol. 2017 May 5;802:36-43. doi: 10.1016/j.ejphar.2017.02.039. Epub 2017 Feb 24. Eur J Pharmacol. 2017. PMID: 28238769
Non-hemorrhagic acute complications associated with cirrhosis and portal hypertension.
Loo NM, Souza FF, Garcia-Tsao G. Loo NM, et al. Best Pract Res Clin Gastroenterol. 2013 Oct;27(5):665-78. doi: 10.1016/j.bpg.2013.08.005. Epub 2013 Sep 5. Best Pract Res Clin Gastroenterol. 2013. PMID: 24160926 Review.

See all similar articles

References

1. Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 2012;16:133–46. - PubMed
1. Bleibel W, Al-Osaimi AM. Hepatic encephalopathy. Saudi J Gastroenterol. 2012;18:301–9. - PMC - PubMed
1. Lawrence KR, Klee JA. Rifaximin for the treatment of hepatic encephalopathy. Pharmacotherapy. 2008;28:1019–32. - PubMed
1. Zullo A, Hassan C, Ridola L, Lorenzetti R, Campo SM, et al. Rifaximin therapy and hepatic encephalopathy: Pros and cons. World J Gastrointest Pharmacol Ther. 2012;3:62–7. - PMC - PubMed
1. Riggio O, Masini A, Efrati C, Nicolao F, Angeloni S, Salvatori FM, et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: A randomized controlled study. J Hepatol. 2005;42:674–9. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information